Recalls & Warnings August 30, 2012 FDA Warns of Medical Claims Made For Numerous Chinese Herbal Products On August 15, 2012, the FDA warned Dragon Herbs that promotional statements made on the company's website constitute drug claims for twenty herbal products, including CardioPro 2000, Cordyceps, Duanwood Reishi, Gynostemma, Ginseng and Astragalus Combination, Dang Gui and Gelatin, Sweet Relief,
(2015) 5:e583
The main GMP production line include injection, powder, tablet, granules, premix, pour-on solution, disinfectant and oral solution, etc
This property is particularly relevant in conditions like Alzheimers disease, where metal ion imbalance contributes to disease progression 9